ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway
Abstract Breast cancer has the highest global incidence and mortality rates among all cancer types. Abnormal expression of the Annexin family has been observed in different malignant tumors, including upregulated ANXA9 in breast cancer. We found highly expressed ANXA9 in metastatic breast cancer tis...
Main Authors: | Xiqian Zhou, Junyong Zhao, Tao Yan, Danrong Ye, Yuying Wang, Bai’an Zhou, Diya Liu, Xuehui Wang, Wenfang Zheng, Bowen Zheng, Fengyuan Qian, Yating Li, Dengfeng Li, Lin Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2024-04-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-024-06643-4 |
Similar Items
-
miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer
by: Zhongrui Wang, et al.
Published: (2023-09-01) -
DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP
by: Danrong Ye, et al.
Published: (2023-02-01) -
Neddylation activated TRIM25 desensitizes triple-negative breast cancer to paclitaxel via TFEB-mediated autophagy
by: Bowen Zheng, et al.
Published: (2024-06-01) -
MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor
by: Xiaochong Deng, et al.
Published: (2021-08-01) -
DLAT promotes triple-negative breast cancer progression via YAP1 activation
by: Diya Liu, et al.
Published: (2024-12-01)